Pharmacist's Influence on Breast Cancer Patient Quality of Life
Not Applicable
Completed
- Conditions
- Breast Cancer, Quality of Life
- Interventions
- Behavioral: Pharmacist's behavioral intervention
- Registration Number
- NCT02746666
- Lead Sponsor
- University Hospital "Sestre Milosrdnice"
- Brief Summary
The purpose of this study is to investigate the impact of pharmacist behavioral intervention's influence on breast cancer patients' quality of life. Croatian randomized controlled trial. Targeted population: general population of breast cancer patients under the first adjuvant anthracycline chemotherapy. Primary outcome: difference in EORTC QLQ-BR23 questionnaire result from the baseline to after 3 week cycle.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
- Early breast cancer
- First adjuvant chemotherapy
- Chemotherapy protocol: anthracycline x 4
Exclusion Criteria
- Cardiovascular comorbidities
- Regular nausea or vomiting during six months before enrollment
- Unable to answer the quality of life questionnaire on their own
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Pharmacist's behavioral intervention Under pharmacist's behavioral intervention
- Primary Outcome Measures
Name Time Method changes in quality of life of a breast cancer patient under chemotherapy, after a clinical pharmacist's behavioral intervention, measured by EORTC B23 questionnaire up to two months
- Secondary Outcome Measures
Name Time Method